Marie-anne Welti-Rameix

Université De Versailles St. Quentin, M3P, UMR 1173
Paris, 75015, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Double-Stapled Peptide Scan Yields Potent Fusion Inhibitors of Respiratory Syncytial Virus.

Double-Stapled Peptide Scan Yields Potent Fusion Inhibitors of Respiratory Syncytial Virus.

Journal: Journal of medicinal chemistry

Published: May 27, 2026

Accounting for Defective Viral Genomes in viral consensus genome reconstruction, application to influenza virus.

Accounting for Defective Viral Genomes in viral consensus genome reconstruction, application to influenza virus.

Journal: PLoS computational biology

Published: March 09, 2026

Identification of the causal odds ratio in test-negative-design studies of COVID-19 vaccine effectiveness.

Identification of the causal odds ratio in test-negative-design studies of COVID-19 vaccine effectiveness.

Journal: International journal of epidemiology

Published: January 12, 2026

Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1.

Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1.

Journal: Nature communications

Published: November 07, 2025

Direct interaction between RSV polymerase L and active Rab11a mediates viral ribonucleoprotein transport to assembly sites.

Direct interaction between RSV polymerase L and active Rab11a mediates viral ribonucleoprotein transport to assembly sites.

Journal: PLoS pathogens

Published: October 27, 2025

Direct interaction between RSV polymerase L and active Rab11a mediates viral ribonucleoprotein transport to assembly sites.

Direct interaction between RSV polymerase L and active Rab11a mediates viral ribonucleoprotein transport to assembly sites.

Journal: PLoS pathogens

Published: October 27, 2025

Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France.

Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France.

Journal: The Lancet. Microbe

Published: October 21, 2025

Immunocompromised patients with persistent SARS-CoV-2 viral shedding ≥8 weeks, clinical outcomes, and virological dynamics: a retrospective multicenter cohort study, 2020-2024.

Immunocompromised patients with persistent SARS-CoV-2 viral shedding ≥8 weeks, clinical outcomes, and virological dynamics: a retrospective multicenter cohort study, 2020-2024.

Journal: Antimicrobial agents and chemotherapy

Published: September 26, 2025

Prophylactic monoclonal antibodies against respiratory syncytial virus in early life: An in-depth review of mechanisms of action, failure factors, and future perspectives.

Prophylactic monoclonal antibodies against respiratory syncytial virus in early life: An in-depth review of mechanisms of action, failure factors, and future perspectives.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: September 12, 2025

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

Journal: EBioMedicine

Published: September 10, 2025

Visualization of Respiratory Syncytial Virus RNA Synthesis Sites by Ethynyl Uridine Labeling.

Visualization of Respiratory Syncytial Virus RNA Synthesis Sites by Ethynyl Uridine Labeling.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 29, 2025

Visualizing Respiratory Syncytial Virus Replication in Live Mice.

Visualizing Respiratory Syncytial Virus Replication in Live Mice.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 29, 2025

Showing 1-12 of 70

Last Updated: 09/26/2026